Colorectal cancer is the third leading cause of cancer death in both males and females in the U.S. The overall, long-term goal of the Chemoprevention of Colon Cancer Program Project is to reduce the incidence, morbidity and mortality of colorectal cancer. To accomplish this goal, we seek to develop highly effective intervention strategies to prevent the recurrence of sporadic adenomatous polyps in subjects at increased risk for colon cancer and to define the fundamental epigenetic and genetic mechanisms of polyp genesis and recurrence. Our Program Project consists of three highly interactive scientific research components and will complete two large cancer control phase III studies in 2800 participants as follows: 1. A phase III randomized, placebo-controlled, double-blind cancer control study of the effect of ursodeoxycholic acid on recurrence of adenomatous polyps, with emphasis on proving the bile acid hypothesis that colon carcinogenesis is a progressive disorder of signal transduction involving the interaction of fat, bile acids and bacteria; 2. A phase II randomized, placebo-controlled, double-blind study of factorial design of the effect of celecoxib, a COX-2 inhibitor, and selenium (formulated in backer's yeast), a nutritional supplement, and their combination on adenoma recurrence. These agents were selected because of their different mechanistic effects on the colon carcinogenesis signal transduction pathway, well-documented activity in animal models and safety profiles established in human studies; 3. An examination of CpG island methylator phenotype (CIMP) abnormalities, specific genetic alterations (APC, Ki-ras, p53), and biologic perturbations (PCNA, COX, apoptosis) in baseline adenomas and age-related DNA methylation and nuclear chromatin patterns in rectal mucosal biopsies, as predictors of adenomas recurrence; and 4. Project of factors enhancing susceptibility to colon carcinogenesis, including environmental/lifestyle characteristics and high prevalence polymorphisms in enzymes involved in folate metabolism and metabolism of heterocyclic amines, and their interaction with genetic and epigenetic mechanisms in relation to risk of adenoma recurrence. To accomplish our goals, we have brought together a group of outstanding cancer researchers who have developed a highly integrated, hypothesis-driven research proposal with a strong likelihood of success that was grafted so that will Projects and Core Services within six large universities depend scientifically and operationally on each other.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041108-18
Application #
6787305
Study Section
Subcommittee G - Education (NCI)
Program Officer
Malone, Winfred F
Project Start
1986-09-30
Project End
2005-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
18
Fiscal Year
2004
Total Cost
$3,303,120
Indirect Cost
Name
University of Arizona
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Lance, Peter; Alberts, David S; Thompson, Patricia A et al. (2017) Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prev Res (Phila) 10:45-54
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst 108:
Jacobs, Elizabeth T; Haussler, Mark R; Alberts, David S et al. (2016) Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer Prev Res (Phila) 9:589-97
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst 108:
Hibler, Elizabeth A; Sardo Molmenti, Christine L; Dai, Qi et al. (2016) Physical activity, sedentary behavior, and vitamin D metabolites. Bone 83:248-255
Hibler, Elizabeth A; Klimentidis, Yann C; Jurutka, Peter W et al. (2015) CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutr Cancer 67:1131-41
Minasian, Lori M; Tangen, Catherine M; Wickerham, D Lawrence (2015) Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol 42:748-63
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Molmenti, Christine L Sardo; Hibler, Elizabeth A; Ashbeck, Erin L et al. (2014) Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25:1387-95

Showing the most recent 10 out of 149 publications